TP53 and pancreatic adenocarcinoma: The frequency of p53 mutations in endocrine cancers is varying, it is ~55% in pancreatic adenocarcinoma and ovarian serous cystadenocarcinoma, only 0.4% in thyroid carcinoma and 3.2% in thymoma (Figure 1A).